A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Rezolute, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 19,799 shares of RZLT stock, worth $76,226. This represents 0.03% of its overall portfolio holdings.

Number of Shares
19,799
Previous 13,329 48.54%
Holding current value
$76,226
Previous $64.6 Million 50.07%
% of portfolio
0.03%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$4.08 - $5.96 $26,397 - $38,561
6,470 Added 48.54%
19,799 $97 Million
Q3 2024

Nov 14, 2024

BUY
$4.13 - $5.31 $55,048 - $70,776
13,329 New
13,329 $64.6 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $149M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.